Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave—A Single Center Experience

Superinfections with <i>Aspergillus</i> spp. in patients with Coronavirus disease 2019 (CAPA: COVID-19-associated pulmonary aspergillosis) are increasing. Dexamethasone has shown beneficial effects in critically ill COVID-19 patients. Whether dexamethasone increases the risk of CAPA has not been stu...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Simon Dubler, Ömer Can Turan, Karsten Daniel Schmidt, Peter-michael rath, Hedda-Luise Verhasselt, Sandra Maier, Annabell Skarabis, Thorsten Brenner, Frank Herbstreit
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-12-01
coleção:	Diagnostics
Assuntos:	COVID-19 CAPA <i>Aspergillus fumigatus</i> dexamethasone intensive care medicine ICU
Acesso em linha:	https://www.mdpi.com/2075-4418/12/12/3049
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!